17. Pogun S, Rodopman Arman A. Understanding nicotine addiction and the health effects of nicotine use. In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 18–32. 18. Pisinger C, Katsaounou P, Belo Ravara S, et al. E-cigarettes, heated tobacco and other novel nicotine-containing products: a help to smokers or a public health threat? In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 33–55. 19. Martínez C, Schoretsaniti S, Bobak A, et al. Behaviour counselling and psychosocial interventions. The role of patient involvement. In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 76–96. 20. Liakoni E, Benowitz NL. Evidence of the effectiveness and safety of first-line smoking cessation pharmacotherapy. In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 97–117. 21. Johnston L, Hilton C, Dempsey F. Practical guidance on the use of motivational interviewing to support behaviour change. In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 56–75. 22. Lewis KE, Belo Ravara S, Papadakis S, et al. Optimising health systems to deliver tobacco-dependence treatment. In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 118–135. 23. Papadakis S, Pipe A, Vlachopoulos C, et al. Cardiovascular patients. In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 208–228. 24. Rice S, Sharaf GM, Kyriakakis N, et al. Patients with common endocrine disorders. In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 229–247. 25. Stockings E, Metse A, Taylor G. “It’s the one thing they have left”: smoking, smoking cessation and mental health. In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 248–272. 26. Barnes PJ, Adcock IM, Mumby S, et al. Asthmatic patients. In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 136–153. 27. Karadag B, Dağli E, Yildiz F. Preventing tobacco use and exposure to second-hand tobacco smoke in pregnancy. In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 273–286. 28. Dağli E, Dilektaşli AG, Pisinger C. Preventing the initiation of tobacco and e-cigarettes among the youth. In: Belo Ravara S, Dağli E, Katsaounou P, et al., eds. Supporting Tobacco Cessation (ERS Monograph). Sheffield, European Respiratory Society, 2021 pp. 287–307. Disclosures: P. Katsaounou reports receiving the following, outside the submitted work: grants from Pfizer advisory fees and honoraria from GSK, AstraZeneca, Chiesi and Pfizer. P. Katsaounou is a recipient of grants – Aristeia, a Global Research Awards for Nicotine Dependence Grant – and a collaborator at Eurest-Plus, Joint Action for Tobacco Control Grants. K.E. Lewis reports receiving the following, outside the submitted work: speaker fees from Pfizer and Novartis speaker fees and fees for attendance at conferences from GSK and AstraZeneca. K.E. Lewis is lead or co-applicant on grants worth over €25 million. Acknowledgements: We would like to express our immense gratitude to all of our co-authors and peer reviewers for their relevant contribution to and the effort they have made toward this Monograph, particularly in such difficult COVID-19 pandemic times. xiv https://doi.org/10.1183/2312508X.10026720